Kidney cancer patients who had already tried two or three different treatments had improved chances of preventing cancer progression with an experimental drug called tivozanib compared to an alternative approved by the U.S. ...
Dec 4, 2019
0
1
A Michigan State University study led by a physiology graduate student in the College of Human Medicine has found that new drug combinations may prevent melanoma, an often deadly form of skin cancer, from becoming resistant ...
Nov 11, 2019
0
20
For several years, the national spotlight has shone on the need to prevent and rapidly treat opioid overdoses. But a new study suggests a need for more focus on the risk of alcohol overdoses among people who use opioids of ...
Oct 12, 2019
0
4
A new therapeutic being tested by University of Alberta researchers is showing early promise as a more effective treatment that could help nearly half of patients with Duchenne muscular dystrophy (DMD).
Sep 25, 2019
0
12
Seven years ago, Jason Esterhuizen was in a horrific car crash that destroyed his eyes, plunging him into total darkness. Today, he's regained visual perception and more independence, thanks to an experimental device implanted ...
Sep 19, 2019
0
105
Research shows that controlling inflammation may be key to helping the brain develop the flexibility to respond to antidepressant drugs, potentially opening the way for treatment for many millions of people who do not respond ...
Sep 10, 2019
0
1
In the field of addiction research, one question looms large: Why do some people face a higher risk than others for alcoholism and drug abuse? A researcher at the OU College of Medicine, William R. Lovallo, Ph.D., recently ...
Aug 16, 2019
0
3
Five years ago, David C. Fajgenbaum, MD, MBA, MSc, both a Penn Medicine researcher and patient, tried an experimental treatment on himself based on his laboratory research findings in the hopes of saving his own life. He ...
Aug 13, 2019
0
212
An article published in Experimental Biology and Medicine identifies a new target for the treatment of idiopathic pulmonary fibrosis. The study, led by Dr. Huaping Dai in the Department of Pulmonary and Critical Care Medicine ...
Jul 1, 2019
0
6
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis ...
Jun 20, 2019
0
3
